Header Logo

Caroline Alper

Concepts (59)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Medicaid
6
2026
372
0.420
 Why?
Glucagon-Like Peptide 1
1
2026
30
0.230
 Why?
Overweight
1
2026
257
0.200
 Why?
Pharmacies
1
2021
36
0.170
 Why?
Pharmaceutical Services
1
2021
33
0.170
 Why?
Chloride Channel Agonists
1
2019
2
0.150
 Why?
Aminophenols
1
2019
3
0.150
 Why?
Benzodioxoles
1
2019
12
0.150
 Why?
Aminopyridines
1
2019
34
0.150
 Why?
Quinolones
1
2019
25
0.150
 Why?
Drug Combinations
4
2022
166
0.150
 Why?
Uridine Monophosphate
1
2018
8
0.140
 Why?
Fluorenes
1
2018
13
0.140
 Why?
Cystic Fibrosis
1
2019
126
0.140
 Why?
Benzimidazoles
1
2018
56
0.140
 Why?
Obesity
1
2026
1274
0.130
 Why?
Hydrocodone
1
2017
6
0.130
 Why?
Hepatitis C, Chronic
1
2018
89
0.130
 Why?
Drug and Narcotic Control
1
2017
27
0.130
 Why?
Hepacivirus
1
2018
133
0.130
 Why?
Antiviral Agents
1
2018
321
0.110
 Why?
Lung
1
2019
966
0.100
 Why?
Heart Failure
1
2022
957
0.100
 Why?
Retrospective Studies
5
2026
6872
0.090
 Why?
Analgesics, Opioid
1
2017
527
0.090
 Why?
Practice Patterns, Physicians'
1
2017
706
0.090
 Why?
United States
5
2026
8093
0.080
 Why?
Gastric Inhibitory Polypeptide
1
2026
4
0.060
 Why?
Glucagon-Like Peptides
1
2026
8
0.060
 Why?
Anti-Obesity Agents
1
2026
16
0.060
 Why?
Adult
4
2026
17358
0.050
 Why?
Middle Aged
4
2026
18273
0.050
 Why?
Aminobutyrates
1
2022
9
0.050
 Why?
Valsartan
1
2022
12
0.050
 Why?
Tetrazoles
1
2022
22
0.050
 Why?
Biphenyl Compounds
1
2022
30
0.050
 Why?
Angiotensin Receptor Antagonists
1
2022
63
0.040
 Why?
Cost-Benefit Analysis
1
2022
317
0.040
 Why?
Stroke Volume
1
2022
342
0.040
 Why?
Massachusetts
1
2026
2145
0.040
 Why?
Humans
6
2026
65140
0.040
 Why?
Male
4
2026
31047
0.040
 Why?
Cystic Fibrosis Transmembrane Conductance Regulator
1
2019
81
0.040
 Why?
Female
4
2026
34018
0.040
 Why?
Sustained Virologic Response
1
2018
10
0.040
 Why?
Sofosbuvir
1
2018
16
0.040
 Why?
Ribavirin
1
2018
22
0.040
 Why?
Young Adult
2
2019
4809
0.030
 Why?
Treatment Failure
1
2018
208
0.030
 Why?
Controlled Substances
1
2017
4
0.030
 Why?
Adolescent
2
2019
6297
0.030
 Why?
Viral Load
1
2018
230
0.030
 Why?
RNA, Viral
1
2018
266
0.030
 Why?
Drug Therapy, Combination
1
2018
463
0.030
 Why?
Genotype
1
2018
673
0.030
 Why?
Treatment Outcome
1
2026
5792
0.030
 Why?
Mutation
1
2019
2661
0.020
 Why?
Child
1
2019
4607
0.020
 Why?
Aged
1
2018
14965
0.010
 Why?
Alper's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (59)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_